(Reuters via MSN) – The Trump administration has told global vaccine group Gavi to phase out shots containing the preservative thimerosal as a condition of providing the group with funding, a U.S. official and a Gavi spokesperson told Reuters.

The request, which Reuters is the first to report, is the latest sign of efforts by the administration of President Donald Trump to influence health policy globally. (Read More)